Deals in brief: AnyMind Group acquires Indonesia-based DDI, GGV Capital splits into two businesses, eight China deals, and more
Bringing you the latest news briefs on fundraising activities in the Asia Pacific.
Source: kr-asia.com
📰 Origin Biotech News
Origin Biotech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Origin Biotech. Real-time updates on events, politics, business and more.
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy - read this article along with other careers information, tips and advice on BioSpace
Harvard University United States Jin Zhang San Francisco Qilu Pharma Prnewswire Cellorigin Biotech Hangzhou Co Ltd
Source: biospace.com
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy
/PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced it has made a global strategic collaboration agreement with Qilu Pharma to develop,...
Jin Zhang Qilu Pharma Harvard University Prnewswire Cellorigin Biotech Hangzhou Co Ltd Principal Investigator Of Zhejiang University Cellorigin Biotech Hangzhou Co Ltd
Source: prnewswire.com
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy | DNA RNA and Cells
CellOrigin Biotech Announces Global Strategic Collaboration with Qilu Pharma to Develop "Off-the-Shelf" CAR-iMAC Cell Therapy
Jin Zhang Qilu Pharma Harvard University Principal Investigator Of Zhejiang University Cellorigin Biotech Hangzhou Co Ltd Zhejiang University
Source: pipelinereview.com
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy - read this article along with other careers information, tips and advice on BioSpace
Jin Zhang Harvard University Office At Cellorigin Biotech Prnewswire Cellorigin Biotech Hangzhou Co Ltd Cellorigin Biotech Hangzhou Co Ltd Zhejiang University
Source: biospace.com
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy | DNA RNA and Cells
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy
Jin Zhang Harvard University Office At Cellorigin Biotech Cellorigin Biotech Hangzhou Co Ltd Zhejiang University I Cellorigin Biotech Hangzhou Co Ltd
Source: pipelinereview.com
CellOrigin Biotech announced strategic global collaboration with Qilu Pharmaceutical to develop "off-the-shelf" CAR-iMAC cell therapy
/PRNewswire/ -- CellOrigin Biotech (Hangzhou) Co., Ltd. announced that it has made an agreement with Qilu Pharmaceutical on strategic global collaborations to...
Jin Zhang Harvard University Office At Cellorigin Biotech Cellorigin Biotech Hangzhou Co Ltd Zhejiang University Cellorigin Biotech
Source: prnewswire.com
CellOrigin secured a new round of investment for developing its globally proprietary iPSC-CAR-Macrophage technology platform
/PRNewswire/ -- On Oct. 11th, 2021, CellOrigin Inc. released data about its second generation of iPSC-CAR-Macrophage which has a genetically integrated...
United States Jin Zhang First Hospital Of Zhejiang University First Affiliated Hospital Of Zhejiang University Cellorigin Inc Shulan Health
Source: prnewswire.com